Inactive Instrument
RBC Life Sciences Inc. Stock Other OTC
Stocks
US74926T1025
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15-06-30 | RBC Life Sciences, Inc. Approves Resignation of Robert A. Kaiser as a Director | CI |
| 15-03-31 | Tranche Update on RBC Life Sciences Inc.'s Equity Buyback Plan announced on August 28, 2013. | CI |
| Market Cap | 553K 486K 452K 416K 779K 53.56M 793K 5.4M 2.11M 26.13M 2.08M 2.03M 90.64M | P/E 2013 |
-6.74x | P/E 2014 | -4.77x |
|---|---|---|---|---|---|
| Enterprise Value | -232K -204K -189K -174K -327K -22.46M -333K -2.27M -884K -10.95M -871K -852K -38M | EV / Sales 2013 |
0.04x | EV / Sales 2014 | 0.07x |
| Free-Float |
91.69% | Yield 2013 * |
-
| Yield 2014 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.28% | -2.00% | +15.47% | +99.03% | 95.31B | |
| +2.47% | -1.20% | +43.24% | +142.49% | 51.65B | |
| -1.57% | -3.58% | -1.22% | +248.77% | 23.26B | |
| -0.96% | -2.64% | -13.14% | -18.68% | 8.29B | |
| -1.33% | -4.91% | -29.31% | -30.77% | 7.98B | |
| -0.35% | -3.76% | -12.65% | -28.80% | 6.76B | |
| -0.84% | +1.48% | +25.62% | +27.58% | 6.29B | |
| -2.63% | -1.47% | -0.91% | +20.46% | 5.48B | |
| 0.00% | -3.25% | -6.47% | -7.22% | 3.73B | |
| Average | -0.41% | -0.21% | +2.29% | +50.32% | 23.19B | |
| Weighted average by Cap. | +0.83% | -1.44% | +16.21% | +106.58% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 25.47M 22.4M 20.81M 19.14M 35.89M 2.47B 36.54M 249M 97.07M 1.2B 95.62M 93.55M 4.17B | 28.27M 24.86M 23.1M 21.24M 39.84M 2.74B 40.55M 276M 108M 1.34B 106M 104M 4.63B |
| Net income | -500K -440K -409K -376K -705K -48.42M -717K -4.89M -1.91M -23.62M -1.88M -1.84M -81.94M | -603K -530K -493K -453K -850K -58.38M -865K -5.89M -2.3M -28.47M -2.26M -2.21M -98.78M |
| Net Debt | -2.4M -2.11M -1.96M -1.8M -3.38M -232M -3.44M -23.42M -9.13M -113M -9M -8.8M -393M | -785K -690K -641K -590K -1.11M -76.02M -1.13M -7.67M -2.99M -37.08M -2.95M -2.88M -129M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
